Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,938 | -81,889 | -63,189 | -44,934 | -22,290 |
| Depreciation Amortization | 1,250 | 5,089 | 4,763 | 3,540 | 1,521 |
| Accounts receivable | -1,611 | -236 | -1,687 | -146 | -1,072 |
| Accounts payable and accrued liabilities | -63 | -1,311 | -588 | 705 | -168 |
| Other Working Capital | -2,882 | 39,909 | 34,525 | 2,223 | 113 |
| Other Operating Activity | 3,545 | 19,166 | 13,393 | 8,323 | 5,095 |
| Operating Cash Flow | $-11,699 | $-19,272 | $-12,783 | $-30,289 | $-16,801 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -143 | -12,896 | -11,438 | -11,283 | -8,745 |
| Purchase Of Investment | -148,624 | -209,629 | -141,008 | -55,016 | N/A |
| Sale Of Investment | 101,469 | 262,872 | 190,497 | 130,833 | 77,648 |
| Investing Cash Flow | $-47,298 | $40,347 | $38,051 | $64,534 | $68,903 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 141 | 145 | 94 | 94 | 94 |
| Other Financing Activity | 63,995 | -26,763 | -18,391 | -11,967 | -5,080 |
| Financing Cash Flow | $64,136 | $-26,618 | $-18,297 | $-11,873 | $-4,986 |
| Beginning Cash Position | 35,658 | 41,201 | 41,201 | 41,201 | 41,201 |
| End Cash Position | 40,797 | 35,658 | 48,172 | 63,573 | 88,317 |
| Net Cash Flow | $5,139 | $-5,543 | $6,971 | $22,372 | $47,116 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,699 | -19,272 | -12,783 | -30,289 | -16,801 |
| Capital Expenditure | -143 | -12,896 | -11,438 | -11,283 | -8,745 |
| Free Cash Flow | -11,842 | -32,168 | -24,221 | -41,572 | -25,546 |